IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSNATI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.398
EU - Europa 6.662
AS - Asia 2.237
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 12
OC - Oceania 10
Totale 19.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.376
PL - Polonia 3.373
CN - Cina 1.529
UA - Ucraina 1.272
DE - Germania 569
IT - Italia 465
HK - Hong Kong 390
FI - Finlandia 308
GB - Regno Unito 239
IE - Irlanda 210
VN - Vietnam 123
FR - Francia 117
IN - India 95
TR - Turchia 32
SE - Svezia 26
BE - Belgio 21
CA - Canada 21
IR - Iran 19
SG - Singapore 17
NL - Olanda 15
EU - Europa 14
ES - Italia 11
AU - Australia 10
RU - Federazione Russa 10
MU - Mauritius 9
IL - Israele 7
BR - Brasile 5
DK - Danimarca 4
MA - Marocco 4
SA - Arabia Saudita 4
CL - Cile 3
EC - Ecuador 3
EE - Estonia 3
JP - Giappone 3
PK - Pakistan 3
AL - Albania 2
BD - Bangladesh 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
KR - Corea 2
LK - Sri Lanka 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 19.351
Salva come PNG Salva come JPEG
Città #
Warsaw 3.372
Fairfield 1.667
Woodbridge 1.275
Jacksonville 955
Houston 870
Ashburn 744
Cambridge 711
Ann Arbor 605
Wilmington 599
Seattle 566
Chandler 503
Princeton 397
Hong Kong 388
Nanjing 346
Beijing 278
Dublin 209
New York 182
Dearborn 154
Helsinki 133
Nanchang 125
Dong Ket 122
Brescia 103
San Diego 85
Shenyang 83
Des Moines 80
Jinan 79
Hebei 74
Changsha 71
Jiaxing 65
Lancaster 62
Tianjin 58
Milan 57
Kunming 45
Hangzhou 40
Shanghai 36
Verona 34
San Mateo 32
London 31
Augusta 30
San Francisco 29
Haikou 27
Rome 26
Lanzhou 25
Leawood 25
Kocaeli 24
Ningbo 24
Phoenix 24
Zhengzhou 23
Norwalk 22
Brussels 18
Taizhou 18
Boardman 17
Taiyuan 17
Changchun 16
Fuzhou 16
Monmouth Junction 16
Ardabil 14
Kilburn 14
Parma 14
Toronto 14
Guangzhou 13
Los Angeles 12
Hefei 11
Redwood City 11
Florence 10
Orange 10
Falls Church 9
Indiana 8
Beersheba 6
Dronten 6
Southwark 6
Washington 6
Markham 5
Melbourne 5
New Bedfont 5
Padova 5
Wandsworth 5
Acton 4
Amsterdam 4
Auburn Hills 4
Catania 4
Como 4
Madrid 4
Riyadh 4
Bernareggio 3
Canberra 3
Chicago 3
Chiswick 3
Falkenstein 3
Fiorenzuola D'arda 3
Islamabad 3
Jinhua 3
L'aquila 3
Lucca 3
Montesilvano Marina 3
Mumbai 3
Naples 3
Pian Camuno 3
Ponte San Pietro 3
Siena 3
Totale 15.898
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 267
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures. 259
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 243
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 237
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 233
Biological role of immunoglobulin Free light chains interactomes 224
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 221
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 220
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 215
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 214
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 212
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 211
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 211
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 210
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 208
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 208
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 208
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 202
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 201
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 199
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 198
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 196
The FGF2-binding domain of thrombospondin-1: functional characterization and exploitation to design antiangiogenic compounds 189
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 183
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 179
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 178
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 175
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 171
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 168
Chemoselective surface immbolization of proteins through a cleavable peptide 158
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 157
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 157
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 156
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 151
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 150
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 143
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 142
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 138
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 137
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 123
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 120
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 119
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 118
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 115
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 115
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 114
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 114
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 114
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library 112
Sialic acid as a target for the development of novel antiangiogenic strategies 112
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 111
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 110
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 109
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 109
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 107
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures 106
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 106
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 106
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 106
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 105
Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cells. 104
Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue 104
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 101
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 101
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. 101
Targeting fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis 101
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 101
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 101
Heparin derivatives as angiogenesis inhibitors 100
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. 100
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 100
Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. 98
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 98
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 97
Biochemical bases of the interaction of the human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies 97
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 97
The Impact of Surface Plasmon Resonance in Virology 97
High molecular weight immunoreactive basic fibroblast growth factor-like proteins in rat pituitary and brain. 96
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 96
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis 94
Interaction of angiogenic growth factors with endothelial cell heparan sulfate proteoglycans: implications for the development of angiostatic compounds 94
Liver DNA damage by chemical carcinogens: role of thyroid hormones 94
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 94
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 94
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 93
Multispot, label-free biodetection at a phantom plastic-water interface. 93
Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery. 93
Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans 92
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. 92
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 92
Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 tat-induced angiogenesis and is poorly expressed in KS lesions 91
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 91
Dendritic cell-endothelial cell cross-talk in angiogenesis. 91
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 91
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 91
Undersulfated and glycol-split heparins endowed with antiangiogenic activity 90
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 90
Positively charged peptides can interact with each other as revealed by solid phase binding assays 89
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 89
Fibroblast growth factor-2 in angiogenesis 88
Totale 13.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.437 0 0 0 0 0 0 0 0 0 366 584 487
2019/20206.162 715 270 282 676 403 691 615 622 468 810 276 334
2020/20213.605 110 383 122 489 185 394 136 423 458 280 409 216
2021/20221.785 93 423 30 43 24 69 123 119 84 235 141 401
2022/20231.409 219 59 56 93 106 382 9 149 198 18 48 72
2023/20241.198 93 30 137 68 67 235 52 69 403 44 0 0
Totale 19.735